Lucchini, Matteo http://orcid.org/0000-0002-0447-2297
Prosperini, Luca
Buscarinu, Maria Chiara
Centonze, Diego
Conte, Antonella
Cortese, Antonio
Elia, Giorgia
Fantozzi, Roberta
Ferraro, Elisabetta
Gasperini, Claudio
Ianniello, Antonio
Landi, Doriana
Marfia, Girolama Alessandra
Nociti, Viviana
Pozzilli, Carlo
Salvetti, Marco
Tortorella, Carla
Mirabella, Massimiliano http://orcid.org/0000-0002-7783-114X
Funding for this research was provided by:
Università Cattolica del Sacro Cuore
Article History
Received: 17 November 2020
Revised: 13 January 2021
Accepted: 15 January 2021
First Online: 26 January 2021
Compliance with ethical standards
:
: ML: travel grants from Roche, Biogen, Novartis, Almirall and Sanofi-Genzyme; speaking and/or consulting fees from Biogen, Novartis, Merck-Serono and Almirall. LP: personal fees and non-financial support from Biogen, Celgene, Genzyme, Merck, Mylan, Novartis, Roche, Teva; research grants from Genzyme and Fondazione Italiana Sclerosi Multipla. MCB: has served on advisory boards for Teva, Meck, Roche, Sanofi-Genzyme and Novartis and has received speaker or writing honoraria from Teva, Biogen, Roche, Almirall, Sanofi-Genzyme. DC: advisory Board member of Almirall, Bayer Schering, Biogen, GW Pharmaceuticals, Merck Serono, Novartis, Roche, Sanofi-Genzyme and Teva, and received honoraria for speaking or consultation fees from Almirall, Bayer Schering, Biogen, GW Pharmaceuticals, Merck Serono, Novartis, Roche, Sanofi-Genzyme and TEVA. ACon: nothing to disclose. ACor: speaker honoraria from Biogen, Sanofi Genzyme, Teva; travel grants from Biogen, Merck, Sanofi Genzyme, Teva; advisory boards member honoraria from Biogen, Merck, Novartis, Teva. GE: nothing to disclose. RF: advisory Board member of Novartis, Merck Serono and Roche and received honoraria for consultation fees from Roche, Teva and Mylan. EF: speaker honoraria from Biogen, Merck; travel grants from Merck, Sanofi Genzyme, Teva, Novartis; advisory boards member honoraria from Biogen, Merck, Novartis, Teva, Sanofi Genzyme. CG: honoraria for speaking and travel grants from Roche, Biogen, Sanofi-Aventis, Merck, Bayer-Schering, Teva, Genzyme, Almirall and Novartis. AI: nothing to disclose. DL: received travel funding from Biogen, Merck-Serono, Sanofi-Genzyme, Teva, speaking or consultations fees from Sanofi-Genzyme, Merck-Serono, Teva, Biogen, Roche. GAM: received speaking or consultation fees from Almirall, Bayer-Schering, Biogen, Genzyme, Merck-Serono, Novartis, Teva, Sanofi-Genzyme. VN: honoraria for speaking, advisory board, consulting from Teva, Sanofi-Genzyme, Almirall, Biogen, Bayer Schering, Merck, Novartis. CP: has served on scientific advisory boards for Actelion, Biogen, Genzyme, Hoffmann-La Roche, Merck, Novartis, Sanofi, Teva, and Almirall and has received consulting and/or speaking fees, research support and travel grants from Almirall, Biogen, Genzyme, Hoffmann-La Roche Merck, Novartis, and Teva. MS: speaking honoraria and research support from Biogen, Merck, Novartis, Sanofi, Roche, Teva. CT: honoraria for speaking and travel grants from Roche, Biogen, Sanofi-Aventis, Merck, Bayer-Schering, Teva, Genzyme, Almirall and Novartis. MM: scientific advisory board membership of Bayer Schering, Biogen, Sanofi-Genzyme, Merck, Novartis, Teva; consulting and/or speaking fees, research support or travel grants from Almirall, Bayer Schering, Biogen, CSL Behring, Sanofi-Genzyme, Merck, Novartis, Teva, Roche, Ultragenix; principal investigator in clinical trials for Biogen, Merck, Novartis, Roche, Sanofi Genzyme, Teva, Ultragenix.
: All data were gathered after approval by Ethics Committee of the Fondazione Policlinico Universitario A. Gemelli IRCCS and after obtaining written informed consent by each participant. This study was conducted in accordance with specific national laws and the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. This study did not interfere in the care received by patients.
: Patients signed a written informed consent.
: All the authors have given final approval of the version of the manuscript to be submitted.